SCHEMBL3398443

SCHEMBL3398443

Cc1ccc(F)c(N(C(N)=O)c2ccc(-c3ccc(OC(F)(F)F)c4onc(N)c34)cc2)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 17/20 0.64
FLT3 P36888 16/20 0.64
KIT P10721 15/20 0.64
FLT1 P17948 7/20 0.51
CSF1R P07333 6/20 0.51
TEK Q02763 3/20 0.51
PDGFRB P09619 2/20 0.51
LCK P06239 4/20 0.48
FYN P06241 4/20 0.48
LYN P07948 4/20 0.48
FLT4 P35916 4/20 0.48
BLK P51451 4/20 0.48
SRC P12931 3/20 0.48
ABL1 P00519 2/20 0.48
AURKA O14965 3/20 0.47
ROCK2 O75116 3/20 0.47
RPS6KA5 O75582 3/20 0.47
MAP4K4 O95819 3/20 0.47
NTRK1 P04629 3/20 0.47
RET P07949 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27657403 0.90 KDR (0.53) KDRFLT3KITFLT1CSF1R
SCHEMBL28760137 0.88 KDR (0.52) KDRFLT3KITFLT1CSF1R
SCHEMBL27657319 0.85 KDR (0.55) KDRFLT3KITFLT1CSF1R
SCHEMBL422243 0.83 KDR (0.57) KDRFLT3KITFLT1CSF1R
SCHEMBL27636420 0.83 KDR (0.53) KDRFLT3KITFLT1CSF1R
SCHEMBL27657343 0.81 KDR (0.51) KDRFLT3KITFLT1CSF1R
SCHEMBL5310826 0.81 KDR (0.69) KDRFLT3KITFLT1CSF1R
SCHEMBL5251524 0.80 KDR (0.50) KDRFLT3KITFLT1CSF1R
SCHEMBL27657281 0.79 KDR (0.47) KDRFLT3KITFLT1CSF1R
SCHEMBL5309107 0.79 KDR (0.51) KDRFLT3KITFLT1CSF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2246333-B1 Indazole, benzisoxazole, and benzisothiazole kinase inhibitors ABBOTT LAB (US) 2012-10-24 EP claimed
EP-2246333-A1 Indazole, benzisoxazole, and benzisothiazole kinase inhibitors Abbott Laboratories (US) 2010-11-03 EP claimed